LivaNova PLC (LIVN, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. LivaNova PLC is a medical technology company formed by the merger of Sorin S.p.A, engaged in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation. LivaNova PLC has a market cap of $3.45 billion; its shares were traded at around $71.25 with and P/S ratio of 3.17. GuruFocus has detected 3 severe warning signs with LivaNova PLC. .
For the last quarter LivaNova PLC reported a revenue of $287.6 million, compared with the revenue of $297.0 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $1.1 billion, a decrease of 2.1% from the previous year. For the complete 30-year financial data, please go here.. For the last five years LivaNova PLC had an average revenue growth rate of 36.1% a year.
The reported loss per diluted share was $3.21 for the year, compared with the loss per share of $2.17 in the previous year. The LivaNova PLC had an operating margin of 4.48%, compared with the operating margin of -18.77% a year before. The 10-year historical median operating margin of LivaNova PLC is 23.90%. The profitability rank of the company is 8 (out of 10).
At the end of the fiscal year, LivaNova PLC has the cash and cash equivalents of $61.1 million, compared with $47.2 million in the previous year. The long term debt was $306.3 million, compared with $139.5 million in the previous year. The interest coverage to the debt is 3.4. LivaNova PLC has a financial strength rank of 5 (out of 10).
At the current stock price of $71.25, LivaNova PLC is traded at 35% discount to its historical median P/S valuation band of $109.60. The P/S ratio of the stock is 3.17, while the historical median P/S ratio is 4.48. The stock lost 26.94% during the past 12 months.
CEO Recent Trades:
- CEO Damien Mcdonald sold 1,000 shares of LIVN stock on 02/03/2020 at the average price of $68. The price of the stock has increased by 4.78% since.
For the complete 20-year historical financial data of LIVN, click here.
